Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Will leverage Cryoport's logistics solutions to ensure safe and fully monitored transport of Adaptimmune’s cell therapies
October 9, 2019
By: Kristin Brooks
Managing Editor, Contract Pharma
Adaptimmune Therapeutics, a developer of T-cell therapies to treat cancer, and Cryoport, Inc., a temperature-controlled logistics solutions company dedicated to the life sciences industry, have entered a three-year agreement to ensure safe and fully monitored transport of Adaptimmune’s cell therapies. Adaptimmune aims to optimize manufacturing and supply operations and reduce “vein-to-vein” time for patients in clinical trials and ahead of commercialization. This agreement with Cryoport will contribute to this, alongside other solutions including investment in the latest systems and technology, digitization of the supply chain information, and improved communications with patients and healthcare professionals. Cryoport’s SmartPak II Condition Monitoring System provides near real-time information while tracking location, temperature, orientation, humidity, and shock, as well as other factors to enable the transport of temperature sensitive cell therapies. This information is automatically collected and retained by Cryoport’s cloud based Cryoportal Logistics Management Platform, which gives companies the ability to intervene and make corrections while a shipment is in transit. “Rapidly and safely delivering a patient’s cells back to the hospital after the cells have been armed with our TCRs and frozen for shipment is an essential capability for us,” said John Lunger, Adaptimmune’s chief patient supply officer. “Control and monitoring are critical because a simple temperature variation can jeopardize these cells and, ultimately, the product we supply to patients. With Cryoport’s technology and expertise, we will be able to track the conditions, location, and handling of these cells – a key capability as we prepare to ship commercially in 2022.” “Adaptimmune has a robust pipeline of therapies and a strong in-house manufacturing platform which makes us very pleased to be expanding and extending our relationship with them under this new, exclusive logistics agreement. Cryoport’s solution for Adaptimmune is comprehensive and relies upon our world class technologies including the SmartPak II Condition Monitoring System and the Cryoportal Logistics Management Platform. Today’s joint announcement underscores the strong relationship between our companies and highlights the growing importance of temperature-controlled logistics solutions in advancing the life sciences at large,” said Jerrell Shelton, Cryoport CEO.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !